Related references
Note: Only part of the references are listed.Evaluation of Cobas HPV and SeqHPV Assays in the Chinese Multicenter Screening Trial
Hui Du et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2021)
Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki-67 dual-stained cytology-Retrospective insights from ATHENA
Mark H. Stoler et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Levels of anxiety and distress following receipt of positive screening tests in Australia's HPV-based cervical screening programme: a cross-sectional survey
Rachael Helen Dodd et al.
SEXUALLY TRANSMITTED INFECTIONS (2020)
The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China
Jing Zhang et al.
BMC CANCER (2020)
Cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta-analysis
Talia Malagon et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Risk of cervical lesions in high-risk HPV positive women with normal cytology: a retrospective single-center study in China
Zhiling Wang et al.
INFECTIOUS AGENTS AND CANCER (2020)
The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples
Fangbin Song et al.
PLOS ONE (2020)
Evaluating the Performance of p16INK4a Immunocytochemistry in Cervical Cancer Screening
Fangbin Song et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Type-specific Distribution of Cervical hrHPV Infection and the Association with Cytological and Histological Results in a Large Population-based Cervical Cancer Screening Program: Baseline and 3-year Longitudinal Data
Fangbin Song et al.
JOURNAL OF CANCER (2020)
Factors associated with low adherence to cervical cancer follow-up retest among HPV plus / cytology negative women: a study in programmatic context in a low-income population in Argentina
Juan Gago et al.
BMC CANCER (2019)
Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program
Nicolas Wentzensen et al.
JAMA INTERNAL MEDICINE (2019)
Prevalence of HPV-16/18 genotypes and immediate histopathologic correlation results in a Chinese population with negative cytology and positive high-risk HPV testing
Xiang Tao et al.
CANCER CYTOPATHOLOGY (2019)
Role of HPV Genotype, Multiple Infections, and Viral Load on the Risk of High-Grade Cervical Neoplasia
Rachael Adcock et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology
Mark H. Stoler et al.
GYNECOLOGIC ONCOLOGY (2019)
Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial
Nicole J. Polman et al.
LANCET ONCOLOGY (2019)
Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico
Leticia Torres-Ibarra et al.
JAMA NETWORK OPEN (2019)
Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Joy Melnikow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial
Thomas C. Wright et al.
GYNECOLOGIC ONCOLOGY (2017)
Triage of HPV positive women in cervical cancer screening
Nicolas Wentzensen et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
Five-Year Cervical (Pre)Cancer Risk of Women Screened by HPV and Cytology Testing
Margot H. Uijterwaal et al.
CANCER PREVENTION RESEARCH (2015)
Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: Baseline and longitudinal data
Margot H. Uijterwaal et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
A Study of Genotyping for Management of Human Papillomavirus-Positive, Cytology-Negative Cervical Screening Results
M. Schiffman et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Development and Validation of a New HPV Genotyping Assay Based on Next-Generation Sequencing
Xin Yi et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
The development and evaluation of a community based model for cervical cancer screening based on self-sampling
Jerome L. Belinson et al.
GYNECOLOGIC ONCOLOGY (2014)
The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States
Cosette M. Wheeler et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial
Francesca Carozzi et al.
LANCET ONCOLOGY (2013)
Significance of HPV-58 Infection in Women Who Are HPV-Positive, Cytology-Negative and Living in a Country with a High Prevalence of HPV-58 Infection
Joon Seon Song et al.
PLOS ONE (2013)
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
Debbie Saslow et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Attribution of human papillomavirus types to cervical intraepithelial neoplasia and invasive cancers in southern China
Paul K. S. Chan et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study
Philip E. Castle et al.
LANCET ONCOLOGY (2011)
p16INK4a Is Superior to High-Risk Human Papillomavirus Testing in Cervical Cytology for the Prediction of Underlying High-Grade Dysplasia
Panduka Samarawardana et al.
CANCER CYTOPATHOLOGY (2010)
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjose et al.
LANCET ONCOLOGY (2010)
Share Paper
